Vertical sleeve gastrectomy induces enteroendocrine cell differentiation of intestinal stem cells through bile acid signaling
Authors:
- Ki-Suk KimKKKi-Suk Kim
- Bailey C.E. PeckBPBailey C.E. Peck
- Yu-Han HungYHYu-Han Hung
- Kieran Koch-LaskowskiKKKieran Koch-Laskowski
- Landon WoodLWLandon Wood
- Priya H. DedhiaPDPriya H. Dedhia
- Jason R. SpenceJSJason R. Spence
- Randy J. SeeleyRSRandy J. Seeley
- Praveen SethupathyPSPraveen Sethupathy
- Darleen A. SandovalDSDarleen A. Sandoval
Open Access
- 8 June 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (11)
Abstract
Vertical sleeve gastrectomy (VSG) results in an increase in the number of hormone-secreting enteroendocrine cells (EECs) in the intestinal epithelium; however, the mechanism remains unclear. Notably, the beneficial effects of VSG are lost in a mouse model lacking the nuclear bile acid receptor farnesoid X receptor (FXR). FXR is a nuclear transcription factor that has been shown to regulate intestinal stem cell (ISC) function in cancer models. Therefore, we hypothesized that the VSG-induced increase in EECs is due to changes in intestinal differentiation driven by an increase in bile acid signaling through FXR. To test this, we performed VSG in mice that express EGFP in ISC/progenitor cells and performed RNA-Seq on GFP-positive cells sorted from the intestinal epithelia. We also assessed changes in EEC number (marked by glucagon-like peptide-1, GLP-1) in mouse intestinal organoids following treatment with bile acids, an FXR agonist, and an FXR antagonist. RNA-Seq of ISCs revealed that bile acid receptors are expressed in ISCs and that VSG explicitly alters expression of several genes that regulate EEC differentiation. Mouse intestinal organoids treated with bile acids and 2 different FXR agonists increased GLP-1–positive cell numbers, and administration of an FXR antagonist blocked these effects. Taken together, these data indicate that VSG drives ISC fate toward EEC differentiation through bile acid signaling.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 121995,DK107282,DK107652,P01-DK117821,F32-DK-120159,T32-DK-101357,T32HD57854-10)
- American Diabetes Association (1-19-IBS-252,1-16-ACE-47)
- New York State Department of Health (the Empire State Stem Cell Fund Fellowship)
- Obesity Society (Early Career Award)
This publication has 50 references indexed in Scilit:
- Improved Rodent Maternal Metabolism But Reduced Intrauterine Growth After Vertical Sleeve GastrectomyScience Translational Medicine, 2013
- Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent mannerObesity, 2013
- Alterations in Gut Hormones After Laparoscopic Sleeve GastrectomyAnnals of Surgery, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine, 2012
- Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective TrialObesity Surgery, 2012
- Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cellsDevelopment, 2012
- Is Antagonism of E/Z-Guggulsterone at the Farnesoid X Receptor Mediated by a Noncanonical Binding Site? A Molecular Modeling StudyJournal of Medicinal Chemistry, 2005
- Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7α-hydroxylase geneBiochemical and Biophysical Research Communications, 2003